ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Small Molecule Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-29O929
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Small Molecule Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Oncology Small Molecule Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-29O929
Report
December 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Novartis
Pfizer Inc
Celgene
Bristol–Myers Squibb
Amgen Inc
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
Astrazeneca plc
Astellas
Merck
Biogen Idec
Eisai Co Ltd
TEVA
Otsuka
Ipsen S A
Gilead Sciences
Exelixis Inc

Oncology Small Molecule Drugs Market

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths.
Market Analysis and Insights: Global Oncology Small Molecule Drugs Market
The global Oncology Small Molecule Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Oncology Small Molecule Drugs include Roche, Novartis, Pfizer, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, AbbVie and Sanofi, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Oncology Small Molecule Drugs is widely used in various fields, such as Blood Cancer, Breast Cancer, Gastrointestinal Cancer and Prostate Cancer, etc. Blood Cancer provides greatest supports to the Oncology Small Molecule Drugs industry development. In 2023, global % revenue of Oncology Small Molecule Drugs went into Blood Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Oncology Small Molecule Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oncology Small Molecule Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oncology Small Molecule Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Small Molecule Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oncology Small Molecule Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oncology Small Molecule Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Oncology Small Molecule Drugs Market Report

Report Metric Details
Report Name Oncology Small Molecule Drugs Market
Segment by Type
Segment by Application
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Lung Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Novartis, Pfizer, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, AbbVie, Sanofi, Takeda, Eli Lilly, Bayer, AstraZeneca, Astellas, Merck, Biogen Idec, Eisai, Teva, Otsuka, Ipsen, Gilead Sciences, Exelixis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Oncology Small Molecule Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncology Small Molecule Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Small Molecule Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Oncology Small Molecule Drugs Market report?

Ans: The main players in the Oncology Small Molecule Drugs Market are Roche, Novartis, Pfizer, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, AbbVie, Sanofi, Takeda, Eli Lilly, Bayer, AstraZeneca, Astellas, Merck, Biogen Idec, Eisai, Teva, Otsuka, Ipsen, Gilead Sciences, Exelixis

What are the Application segmentation covered in the Oncology Small Molecule Drugs Market report?

Ans: The Applications covered in the Oncology Small Molecule Drugs Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Other

What are the Type segmentation covered in the Oncology Small Molecule Drugs Market report?

Ans: The Types covered in the Oncology Small Molecule Drugs Market report are Chemotherapy Drugs, Immunomodulating Drugs, Targeted Therapy Drugs, Hormonal Therapy, Other

Recommended Reports

Cancer Drug Markets

Targeted & Small Molecule

Cancer Diagnostics & Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chemotherapy Drugs
1.2.3 Immunomodulating Drugs
1.2.4 Targeted Therapy Drugs
1.2.5 Hormonal Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Small Molecule Drugs Market Perspective (2019-2030)
2.2 Global Oncology Small Molecule Drugs Growth Trends by Region
2.2.1 Oncology Small Molecule Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncology Small Molecule Drugs Historic Market Size by Region (2019-2024)
2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Region (2025-2030)
2.3 Oncology Small Molecule Drugs Market Dynamics
2.3.1 Oncology Small Molecule Drugs Industry Trends
2.3.2 Oncology Small Molecule Drugs Market Drivers
2.3.3 Oncology Small Molecule Drugs Market Challenges
2.3.4 Oncology Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oncology Small Molecule Drugs by Players
3.1.1 Global Oncology Small Molecule Drugs Revenue by Players (2019-2024)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oncology Small Molecule Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2023
3.5 Global Key Players of Oncology Small Molecule Drugs Head office and Area Served
3.6 Global Key Players of Oncology Small Molecule Drugs, Product and Application
3.7 Global Key Players of Oncology Small Molecule Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Small Molecule Drugs Breakdown Data by Type
4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2019-2024)
4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2025-2030)
5 Oncology Small Molecule Drugs Breakdown Data by Application
5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2019-2024)
5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncology Small Molecule Drugs Market Size (2019-2030)
6.2 North America Oncology Small Molecule Drugs Market Size by Type
6.2.1 North America Oncology Small Molecule Drugs Market Size by Type (2019-2024)
6.2.2 North America Oncology Small Molecule Drugs Market Size by Type (2025-2030)
6.2.3 North America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
6.3 North America Oncology Small Molecule Drugs Market Size by Application
6.3.1 North America Oncology Small Molecule Drugs Market Size by Application (2019-2024)
6.3.2 North America Oncology Small Molecule Drugs Market Size by Application (2025-2030)
6.3.3 North America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
6.4 North America Oncology Small Molecule Drugs Market Size by Country
6.4.1 North America Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Oncology Small Molecule Drugs Market Size by Country (2019-2024)
6.4.3 North America Oncology Small Molecule Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oncology Small Molecule Drugs Market Size (2019-2030)
7.2 Europe Oncology Small Molecule Drugs Market Size by Type
7.2.1 Europe Oncology Small Molecule Drugs Market Size by Type (2019-2024)
7.2.2 Europe Oncology Small Molecule Drugs Market Size by Type (2025-2030)
7.2.3 Europe Oncology Small Molecule Drugs Market Share by Type (2019-2030)
7.3 Europe Oncology Small Molecule Drugs Market Size by Application
7.3.1 Europe Oncology Small Molecule Drugs Market Size by Application (2019-2024)
7.3.2 Europe Oncology Small Molecule Drugs Market Size by Application (2025-2030)
7.3.3 Europe Oncology Small Molecule Drugs Market Share by Application (2019-2030)
7.4 Europe Oncology Small Molecule Drugs Market Size by Country
7.4.1 Europe Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Oncology Small Molecule Drugs Market Size by Country (2019-2024)
7.4.3 Europe Oncology Small Molecule Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oncology Small Molecule Drugs Market Size (2019-2030)
8.2 China Oncology Small Molecule Drugs Market Size by Type
8.2.1 China Oncology Small Molecule Drugs Market Size by Type (2019-2024)
8.2.2 China Oncology Small Molecule Drugs Market Size by Type (2025-2030)
8.2.3 China Oncology Small Molecule Drugs Market Share by Type (2019-2030)
8.3 China Oncology Small Molecule Drugs Market Size by Application
8.3.1 China Oncology Small Molecule Drugs Market Size by Application (2019-2024)
8.3.2 China Oncology Small Molecule Drugs Market Size by Application (2025-2030)
8.3.3 China Oncology Small Molecule Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oncology Small Molecule Drugs Market Size (2019-2030)
9.2 Asia Oncology Small Molecule Drugs Market Size by Type
9.2.1 Asia Oncology Small Molecule Drugs Market Size by Type (2019-2024)
9.2.2 Asia Oncology Small Molecule Drugs Market Size by Type (2025-2030)
9.2.3 Asia Oncology Small Molecule Drugs Market Share by Type (2019-2030)
9.3 Asia Oncology Small Molecule Drugs Market Size by Application
9.3.1 Asia Oncology Small Molecule Drugs Market Size by Application (2019-2024)
9.3.2 Asia Oncology Small Molecule Drugs Market Size by Application (2025-2030)
9.3.3 Asia Oncology Small Molecule Drugs Market Share by Application (2019-2030)
9.4 Asia Oncology Small Molecule Drugs Market Size by Region
9.4.1 Asia Oncology Small Molecule Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Oncology Small Molecule Drugs Market Size by Region (2019-2024)
9.4.3 Asia Oncology Small Molecule Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Small Molecule Drugs Introduction
11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Oncology Small Molecule Drugs Introduction
11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oncology Small Molecule Drugs Introduction
11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.3.5 Pfizer Recent Developments
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Oncology Small Molecule Drugs Introduction
11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.4.5 Celgene Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction
11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Oncology Small Molecule Drugs Introduction
11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.6.5 Amgen Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oncology Small Molecule Drugs Introduction
11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.8.5 AbbVie Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Oncology Small Molecule Drugs Introduction
11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.9.5 Sanofi Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Oncology Small Molecule Drugs Introduction
11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.10.5 Takeda Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction
11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.11.5 Eli Lilly Recent Developments
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Oncology Small Molecule Drugs Introduction
11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.12.5 Bayer Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction
11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.13.5 AstraZeneca Recent Developments
11.14 Astellas
11.14.1 Astellas Company Details
11.14.2 Astellas Business Overview
11.14.3 Astellas Oncology Small Molecule Drugs Introduction
11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.14.5 Astellas Recent Developments
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Oncology Small Molecule Drugs Introduction
11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.15.5 Merck Recent Developments
11.16 Biogen Idec
11.16.1 Biogen Idec Company Details
11.16.2 Biogen Idec Business Overview
11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction
11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.16.5 Biogen Idec Recent Developments
11.17 Eisai
11.17.1 Eisai Company Details
11.17.2 Eisai Business Overview
11.17.3 Eisai Oncology Small Molecule Drugs Introduction
11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.17.5 Eisai Recent Developments
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Small Molecule Drugs Introduction
11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Oncology Small Molecule Drugs Introduction
11.19.4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.19.5 Otsuka Recent Developments
11.20 Ipsen
11.20.1 Ipsen Company Details
11.20.2 Ipsen Business Overview
11.20.3 Ipsen Oncology Small Molecule Drugs Introduction
11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.20.5 Ipsen Recent Developments
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Details
11.21.2 Gilead Sciences Business Overview
11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction
11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.21.5 Gilead Sciences Recent Developments
11.22 Exelixis
11.22.1 Exelixis Company Details
11.22.2 Exelixis Business Overview
11.22.3 Exelixis Oncology Small Molecule Drugs Introduction
11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.22.5 Exelixis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roche
Novartis
Pfizer Inc
Celgene
Bristol–Myers Squibb
Amgen Inc
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
Astrazeneca plc
Astellas
Merck
Biogen Idec
Eisai Co Ltd
TEVA
Otsuka
Ipsen S A
Gilead Sciences
Exelixis Inc
List of Tables
    Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chemotherapy Drugs
    Table 3. Key Players of Immunomodulating Drugs
    Table 4. Key Players of Targeted Therapy Drugs
    Table 5. Key Players of Hormonal Therapy
    Table 6. Key Players of Other
    Table 7. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Oncology Small Molecule Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Oncology Small Molecule Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Oncology Small Molecule Drugs Market Share by Region (2019-2024)
    Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Oncology Small Molecule Drugs Market Share by Region (2025-2030)
    Table 13. Oncology Small Molecule Drugs Market Trends
    Table 14. Oncology Small Molecule Drugs Market Drivers
    Table 15. Oncology Small Molecule Drugs Market Challenges
    Table 16. Oncology Small Molecule Drugs Market Restraints
    Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Oncology Small Molecule Drugs Revenue Share by Players (2019-2024)
    Table 19. Global Top Oncology Small Molecule Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2023)
    Table 20. Global Oncology Small Molecule Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Oncology Small Molecule Drugs, Headquarters and Area Served
    Table 23. Global Key Players of Oncology Small Molecule Drugs, Product and Application
    Table 24. Global Key Players of Oncology Small Molecule Drugs, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2019-2024)
    Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2025-2030)
    Table 30. Global Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Oncology Small Molecule Drugs Revenue Share by Application (2019-2024)
    Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Oncology Small Molecule Drugs Revenue Share by Application (2025-2030)
    Table 34. North America Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Oncology Small Molecule Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Oncology Small Molecule Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Oncology Small Molecule Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Roche Company Details
    Table 67. Roche Business Overview
    Table 68. Roche Oncology Small Molecule Drugs Product
    Table 69. Roche Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 70. Roche Recent Developments
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Oncology Small Molecule Drugs Product
    Table 74. Novartis Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 75. Novartis Recent Developments
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Oncology Small Molecule Drugs Product
    Table 79. Pfizer Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 80. Pfizer Recent Developments
    Table 81. Celgene Company Details
    Table 82. Celgene Business Overview
    Table 83. Celgene Oncology Small Molecule Drugs Product
    Table 84. Celgene Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 85. Celgene Recent Developments
    Table 86. Bristol-Myers Squibb Company Details
    Table 87. Bristol-Myers Squibb Business Overview
    Table 88. Bristol-Myers Squibb Oncology Small Molecule Drugs Product
    Table 89. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 90. Bristol-Myers Squibb Recent Developments
    Table 91. Amgen Company Details
    Table 92. Amgen Business Overview
    Table 93. Amgen Oncology Small Molecule Drugs Product
    Table 94. Amgen Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 95. Amgen Recent Developments
    Table 96. Johnson & Johnson Company Details
    Table 97. Johnson & Johnson Business Overview
    Table 98. Johnson & Johnson Oncology Small Molecule Drugs Product
    Table 99. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 100. Johnson & Johnson Recent Developments
    Table 101. AbbVie Company Details
    Table 102. AbbVie Business Overview
    Table 103. AbbVie Oncology Small Molecule Drugs Product
    Table 104. AbbVie Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 105. AbbVie Recent Developments
    Table 106. Sanofi Company Details
    Table 107. Sanofi Business Overview
    Table 108. Sanofi Oncology Small Molecule Drugs Product
    Table 109. Sanofi Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 110. Sanofi Recent Developments
    Table 111. Takeda Company Details
    Table 112. Takeda Business Overview
    Table 113. Takeda Oncology Small Molecule Drugs Product
    Table 114. Takeda Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 115. Takeda Recent Developments
    Table 116. Eli Lilly Company Details
    Table 117. Eli Lilly Business Overview
    Table 118. Eli Lilly Oncology Small Molecule Drugs Product
    Table 119. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 120. Eli Lilly Recent Developments
    Table 121. Bayer Company Details
    Table 122. Bayer Business Overview
    Table 123. Bayer Oncology Small Molecule Drugs Product
    Table 124. Bayer Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 125. Bayer Recent Developments
    Table 126. AstraZeneca Company Details
    Table 127. AstraZeneca Business Overview
    Table 128. AstraZeneca Oncology Small Molecule Drugs Product
    Table 129. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 130. AstraZeneca Recent Developments
    Table 131. Astellas Company Details
    Table 132. Astellas Business Overview
    Table 133. Astellas Oncology Small Molecule Drugs Product
    Table 134. Astellas Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 135. Astellas Recent Developments
    Table 136. Merck Company Details
    Table 137. Merck Business Overview
    Table 138. Merck Oncology Small Molecule Drugs Product
    Table 139. Merck Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 140. Merck Recent Developments
    Table 141. Biogen Idec Company Details
    Table 142. Biogen Idec Business Overview
    Table 143. Biogen Idec Oncology Small Molecule Drugs Product
    Table 144. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 145. Biogen Idec Recent Developments
    Table 146. Eisai Company Details
    Table 147. Eisai Business Overview
    Table 148. Eisai Oncology Small Molecule Drugs Product
    Table 149. Eisai Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 150. Eisai Recent Developments
    Table 151. Teva Company Details
    Table 152. Teva Business Overview
    Table 153. Teva Oncology Small Molecule Drugs Product
    Table 154. Teva Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 155. Teva Recent Developments
    Table 156. Otsuka Company Details
    Table 157. Otsuka Business Overview
    Table 158. Otsuka Oncology Small Molecule Drugs Product
    Table 159. Otsuka Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 160. Otsuka Recent Developments
    Table 161. Ipsen Company Details
    Table 162. Ipsen Business Overview
    Table 163. Ipsen Oncology Small Molecule Drugs Product
    Table 164. Ipsen Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 165. Ipsen Recent Developments
    Table 166. Gilead Sciences Company Details
    Table 167. Gilead Sciences Business Overview
    Table 168. Gilead Sciences Oncology Small Molecule Drugs Product
    Table 169. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 170. Gilead Sciences Recent Developments
    Table 171. Exelixis Company Details
    Table 172. Exelixis Business Overview
    Table 173. Exelixis Oncology Small Molecule Drugs Product
    Table 174. Exelixis Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
    Table 175. Exelixis Recent Developments
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Oncology Small Molecule Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Chemotherapy Drugs Features
    Figure 4. Immunomodulating Drugs Features
    Figure 5. Targeted Therapy Drugs Features
    Figure 6. Hormonal Therapy Features
    Figure 7. Other Features
    Figure 8. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Oncology Small Molecule Drugs Market Share by Application: 2023 VS 2030
    Figure 10. Blood Cancer Case Studies
    Figure 11. Breast Cancer Case Studies
    Figure 12. Gastrointestinal Cancer Case Studies
    Figure 13. Prostate Cancer Case Studies
    Figure 14. Lung Cancer Case Studies
    Figure 15. Other Case Studies
    Figure 16. Oncology Small Molecule Drugs Report Years Considered
    Figure 17. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Oncology Small Molecule Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Oncology Small Molecule Drugs Market Share by Region: 2023 VS 2030
    Figure 20. Global Oncology Small Molecule Drugs Market Share by Players in 2023
    Figure 21. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2023
    Figure 23. North America Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
    Figure 25. North America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
    Figure 26. North America Oncology Small Molecule Drugs Market Share by Country (2019-2030)
    Figure 27. United States Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Oncology Small Molecule Drugs Market Share by Type (2019-2030)
    Figure 31. Europe Oncology Small Molecule Drugs Market Share by Application (2019-2030)
    Figure 32. Europe Oncology Small Molecule Drugs Market Share by Country (2019-2030)
    Figure 33. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Oncology Small Molecule Drugs Market Share by Type (2019-2030)
    Figure 41. China Oncology Small Molecule Drugs Market Share by Application (2019-2030)
    Figure 42. Asia Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Oncology Small Molecule Drugs Market Share by Type (2019-2030)
    Figure 44. Asia Oncology Small Molecule Drugs Market Share by Application (2019-2030)
    Figure 45. Asia Oncology Small Molecule Drugs Market Share by Region (2019-2030)
    Figure 46. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Country (2019-2030)
    Figure 56. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 63. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 64. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 65. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 67. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 68. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 69. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 70. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 71. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 72. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 73. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 74. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 75. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 76. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 77. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 78. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 79. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 80. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 81. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 82. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 83. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Oncology EMR Software Market Insights Forecast to 2030
Cancer Treatment Drugs Market
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Global Breast Cancer Drugs Market Insights Forecast to 2030
Global Oncology and Cancer Treatment Drug Market Research Report 2024
Global Oncology Injection Drug Market Research Report 2025
Global Chemotherapy Drug Market Insights Forecast to 2030
Global Small Molecule Cancer Drug Market Research Report 2025
Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anticancer Drugs Market Research Report 2025
Global Personalized Medicines In Oncology Market Research Report 2024
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Small Molecule Drug Market Research Report 2025
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Global Small Molecule Targeted Anti cancer Drug Market Insights Forecast to 2030
Global Stomach Cancer Drugs Market Insights Forecast to 2030
Platinum Anti tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Medication Management in Oncology Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions